Why is Strides Pharma Science Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 6.00%
- Poor long term growth as Net Sales has grown by an annual rate of 8.61% and Operating profit at 1.20% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 6.85 times
2
54.25% of Promoter Shares are Pledged
- In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
- The proportion of pledged holdings has increased by 5.08% over the last quarter
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Strides Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Strides Pharma
50.77%
1.09
46.57%
SENSEX
0.45%
0.03
14.48%
Quality key factors
Factor
Value
Sales Growth (5y)
8.61%
EBIT Growth (5y)
1.20%
EBIT to Interest (avg)
1.08
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.70
Tax Ratio
23.46%
Dividend Payout Ratio
-6.68%
Pledged Shares
54.25%
Institutional Holding
45.41%
ROCE (avg)
5.59%
ROE (avg)
2.78%
Valuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
33
Price to Book Value
2.36
EV to EBIT
11.50
EV to EBITDA
8.83
EV to Capital Employed
1.72
EV to Sales
1.65
PEG Ratio
0.03
Dividend Yield
0.43%
ROCE (Latest)
13.32%
ROE (Latest)
7.40%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
25What is working for the Company
PAT(HY)
At Rs 164.96 cr has Grown at 98.12 %
PBT LESS OI(Q)
At Rs 110.66 cr has Grown at 319.00 %
ROCE(HY)
Highest at 10.46 %
INVENTORY TURNOVER RATIO(HY)
Highest at 3.59 times
OPERATING PROFIT TO INTEREST(Q)
Highest at 4.03 times
DEBT-EQUITY RATIO(HY)
Lowest at 1.02 times
EPS(Q)
Highest at Rs 9.54
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Strides Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 110.66 cr has Grown at 319.00 %
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 89.87 cr has Grown at 80.9 %
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 4.03 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Inventory Turnover Ratio- Half Yearly
Highest at 3.59 times and Grown
each half year in the last five half yearly periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 110.66 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 89.87 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 9.54
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Debt-Equity Ratio - Half Yearly
Lowest at 1.02 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio